首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   178823篇
  免费   11477篇
  国内免费   707篇
耳鼻咽喉   2503篇
儿科学   4876篇
妇产科学   3435篇
基础医学   23195篇
口腔科学   3546篇
临床医学   17513篇
内科学   38296篇
皮肤病学   2801篇
神经病学   17954篇
特种医学   6213篇
外国民族医学   13篇
外科学   26477篇
综合类   2303篇
现状与发展   3篇
一般理论   201篇
预防医学   13297篇
眼科学   4781篇
药学   11512篇
中国医学   203篇
肿瘤学   11885篇
  2023年   697篇
  2022年   1222篇
  2021年   2862篇
  2020年   1761篇
  2019年   2885篇
  2018年   3396篇
  2017年   2453篇
  2016年   2859篇
  2015年   3454篇
  2014年   5106篇
  2013年   7878篇
  2012年   11388篇
  2011年   12247篇
  2010年   6836篇
  2009年   6305篇
  2008年   11531篇
  2007年   12296篇
  2006年   11800篇
  2005年   12160篇
  2004年   11553篇
  2003年   11025篇
  2002年   10635篇
  2001年   1485篇
  2000年   1125篇
  1999年   1591篇
  1998年   2330篇
  1997年   2020篇
  1996年   1703篇
  1995年   1581篇
  1994年   1423篇
  1993年   1352篇
  1992年   1044篇
  1991年   951篇
  1990年   833篇
  1989年   817篇
  1988年   837篇
  1987年   718篇
  1986年   835篇
  1985年   915篇
  1984年   1221篇
  1983年   1173篇
  1982年   1639篇
  1981年   1513篇
  1980年   1416篇
  1979年   786篇
  1978年   907篇
  1977年   800篇
  1976年   708篇
  1975年   566篇
  1974年   593篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
BACKGROUND: Endovascular radiofrequency obliteration has been used since 1998 as an alternative to conventional vein stripping surgery for elimination of saphenous vein insufficiency. OBJECTIVE: To demonstrate the long-term efficacy of this treatment modality. METHODS: Data were prospectively collected in a multicenter ongoing registry. Only great saphenous vein above-knee treatments were included in this study. Eight hundred ninety patients (1,078 limbs) were treated prior to November 2003 at 32 centers. Clinical and duplex ultrasound follow-up was performed at 1 week, 6 months, and 1, 2, 3, and 4 years. RESULTS: Among 1,078 limbs treated, 858 were available for follow-up within 1 week, 446 at 6 months, 384 at 1 year, 210 at 2 years, 114 at 3 years, and 98 at 4 years. The vein occlusion rates were 91.0%, 88.8%, 86.2%, 84.2%, and 88.8%, respectively; the reflux-free rates were 91.0%, 89.3%, 86.2%, 86.0%, and 85.7%, respectively; and the varicose vein recurrence rates were 7.2%, 13.5%, 17.1%, 14.0%, and 21.4%, respectively, at each follow-up time point at 6 months, and 1, 2, 3, and 4 years. Patient symptom improvement persisted over 4 years. CONCLUSIONS: Endovascular temperature-controlled radiofrequency obliteration of saphenous vein reflux exhibits an enduring treatment efficacy clinically, anatomically, and hemodynamically up to 4 years following treatment.  相似文献   
102.
103.
Anemia has a high prevalence in patients with cancer. Its frequency and severity depend on tumor type, tumor stage, duration of disease, and treatment status. The etiology of cancer-related anemia is multifactorial and includes myelotoxicity of treatment, bone marrow infiltration, impaired erythropoietin production, blood loss, and the anemia of chronic disease. Anemia affects health-related quality of life (QOL) and may impact on tolerance or even outcome of anticancer therapy. Despite its high prevalence and impact on QOL, anemia is often under-recognized and under-treated. Treatment should correct etiologic factors, whenever possible. Symptomatic treatments are red blood cell transfusions and administration of erythropoietic growth factors. Transfusions result in rapid improvement of anemia-related symptoms but are usually only given to patients with moderate to severe anemia. Administration of epoetins (epoetin alfa, epoetin beta) or darbepoetin alfa increases hemoglobin levels, reduces the need for blood transfusions, and improves QOL in patients with cancer-related anemia. Trials determining the exact association of anemia with both response to chemo(radio)therapy and survival are ongoing. Physicians should be aware of the clinical relevance of and treatment options for anemia in cancer patients.  相似文献   
104.
105.
Massive immune hemolysis due to passenger lymphocyte-derived anti-D has not been reported in renal transplantation. A 50-year-old (B-positive) male received a dual deceased-donor kidney transplant (B-negative) for diabetic renal failure. Two weeks post-transplant, the patient developed severe hemolytic anemia. The donor anti-D titer was 1:8. The recipient anti-D titer (zero pre-transplant) increased from 1:4 to 1:16 over 4 days. Rapid hemolysis caused severe anemia, minimum Hb = 4.2 g/dL, while selectively lysing the patient's autologous red cells during this time. The hemolytic anemia did not impair the allografts and subsided without monoclonal B-cell pharmacotherapy or apheresis. The anti-D titer decreased to barely detectable levels at four months and had cleared when checked 2 years post-transplant. Transfusion support subsided after two months. If complications of anemia can be avoided, the deleterious effects of hemolysis may be well tolerated by renal allografts using antigen negative transfusion alone.  相似文献   
106.
Clinical Experience with Light-Emitting Diode (LED) Photomodulation   总被引:1,自引:0,他引:1  
Background. Light-emitting diode (LED) photomodulation is a novel nonthermal technology used to modulate cellular activity with light.
Objective:. We describe our experience over the last 2 years using 590 nm LED photomodulation within a dermatologic surgery environment.
Methods. Practical use of nonthermal light energy and emerging applications in 3,500 treatments delivered to 900 patients is detailed.
Results. LED photomodulation has been used alone for skin rejuvenation in over 300 patients but has been effective in augmentation of results in 600 patients receiving concomitant nonablative thermal and vascular treatments such as intense pulsed light, pulsed dye laser, KTP and infrared lasers, radiofrequency energy, and ablative lasers.
Conclusion:. LED photomodulation reverses signs of photoaging using a new nonthermal mechanism. The anti-inflammatory component of LED in combination with the cell regulatory component helps improve the outcome of other thermal-based rejuvenation treatments.  相似文献   
107.
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号